Ads
related to: sanofi pharmaceuticals
Search results
This French start-up wants to use AI to develop new medicines more quickly
Euronews via Yahoo News· 5 days agoFrench start-up Yseop has partnered with Amazon Web Services (AWS) to use generative AI to assist...
What Our Brains Know About Stocks—But Won’t Tell Us
The Wall Street Journal· 5 days agoAmong the stocks they evaluated: AT&T Carrefour, Ralph Lauren, Sanofi and Teva Pharmaceutical For each stock, the investors viewed a basic profile,...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 5 days agoFurthermore, the company just inked a landmark partnership and licensing deal with French pharmaceutical giant Sanofi earlier this month, which agreed to...
What's the Goal in Treating Type 2 Diabetes?
Medscape· 7 days agoAnne Peters discusses the differences in the newly published American College of Physicians and the American Diabetes Association guidelines for treating...
Dupilumab: Future Treatment for Pediatric Alopecia Areata?
Medscape· 17 hours agoChildren with concomitant atopic dermatitis (AD) and alopecia areata (AA) who were treated with...
Dupilumab Improves Outcomes in COPD With Type 2 Inflammation
Medscape· 2 days agoNew trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.
D.C. Circuit Holds 340B Program Does Not Prohibit Drug Manufacturers from Imposing Contract Pharmacy...
JD Supra· 6 days agoIn the latest legal development in the ongoing 340B contract pharmacy litigation, the United States Court of Appeals for the District of Columbia Circuit ruled earlier this week that the 340B ...
The Petri Dish: Dyne’s public offering, Kronos’ new CFO - Boston Business Journal
The Business Journals· 6 days agoNew money, new people and new partners — this week’s Petri Dish covers it all. Check out the latest...
Biogen's new acquisition target reveals 'provocative' trial results - Boston Business Journal
The Business Journals· 2 days agoJust days after Biogen Inc. announced it was buying Human Immunology Biosciences (HI-Bio) for $1.15...
Public-private collaboration aims to take ALS therapies beyond ‘a shot in the dark’
FierceBiotech· 4 hours agoIn 2015, after spending nearly four decades grinding his way up the ladder at one of the world’s...
